Table 2. Risk of psychiatric emergency associated with antidepressant discontinuation in propensity score–matched cohort analysesa.
Matched groups according to the time of discontinuation of the exposed group | Antidepressant discontinuation group | Antidepressant continuation group | Unadjusted HRs (95% CI) | Adjusted HRs (95% CI)b | p-Values for adjusted analyses | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
No. of women | No. of events | Person-years | Incidence/1,000 person-years | No. of women | No. of events | Person-years | Incidence/1,000 person-years | ||||
Antidepressant discontinuation prior to pregnancy | 2,669 | 76 | 3,309.28 | 23.0 | 2,669 | 91 | 3,258.89 | 27.9 | 0.84 (0.62 to 1.15) | 0.84 (0.61 to 1.16) | 0.298 |
During pregnancy | 2,669 | 40 | 2,002.38 | 20.0 | 2,669 | 52 | 1,959.36 | 26.5 | 0.75 (0.50 to 1.14) | 0.74 (0.47 to 1.15) | 0.175 |
Within 6 months postpartum | 2,578 | 36 | 1,281.34 | 28.1 | 2,578 | 38 | 1,280.20 | 29.7 | 0.97 (0.61 to 1.56) | 0.98 (0.60 to 1.60) | 0.946 |
Antidepressant discontinuation during pregnancy | 5,467 | 202 | 5,335.86 | 37.9 | 5,467 | 156 | 5,312.48 | 29.4 | 1.29 (1.05 to 1.59) | 1.25 (1.00 to 1.55) | 0.048 |
During pregnancy | 5,467 | 92 | 2,677.95 | 34.4 | 5,467 | 58 | 2,632.62 | 22.0 | 1.59 (1.14 to 2.20) | 1.52 (1.08 to 2.15) | 0.016 |
Within 6 months postpartum | 5,316 | 106 | 2,630.23 | 40.3 | 5,316 | 98 | 2,635.26 | 37.2 | 1.15 (0.85 to 1.54) | 1.09 (0.80 to 1.47) | 0.596 |
aThe numbers of cases of psychiatric emergency occurred during pregnancy and within 6 months postpartum do not add up to the whole period since only matched individuals contribute to the analyses.
bAdjustment for imbalanced variables: level of education status and the use of TCAs or MAOIs in the 90 days before pregnancy for the estimate of antidepressant discontinuation before pregnancy and the level of education and age at first affective disorder for the estimate of antidepressant discontinuation during pregnancy.
CI, confidence interval; HR, hazard ratio; MAOI, monoamine oxidase inhibitor; TCA, tricyclic antidepressant.